Insider · CIK 0001058352
William G Skelly
Files at ACUR (ACURA PHARMACEUTICALS, INC). First filing -, latest -.
William G Skelly files SEC Form 4 as director at ACUR (ACURA PHARMACEUTICALS, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; William G Skelly has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | ACUR ACURA PHARMACEUTICALS, INC | MOption exercise Common Stock | +50,000 | - | - | 675,989 | Jan 15, 2026 |
| Jan 2, 2026 | ACUR ACURA PHARMACEUTICALS, INC | MOption exercise Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 0 | Jan 15, 2026 |
| Jan 2, 2026 | ACUR ACURA PHARMACEUTICALS, INC | AGrant or award Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 50,000 | Jan 15, 2026 |
| Jan 2, 2025 | ACUR ACURA PHARMACEUTICALS, INC | MOption exercise Common Stock | +50,000 | - | - | 625,989 | Jan 24, 2025 |
| Jan 2, 2025 | ACUR ACURA PHARMACEUTICALS, INC | MOption exercise Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 0 | Jan 24, 2025 |
| Jan 2, 2025 | ACUR ACURA PHARMACEUTICALS, INC | AGrant or award Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 50,000 | Jan 24, 2025 |
Questions about William G Skelly
Answered from the filings on this page, as of the latest one.
Is William G Skelly buying or selling?
William G Skelly has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did William G Skelly's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William G Skelly has 0.
Where does William G Skelly file Form 4?
William G Skelly has filed Form 4 at ACUR (ACURA PHARMACEUTICALS, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.